DelSite's Costa Rican plant gets OK
This article was originally published in Scrip
Sabila Industrial, the Costa Rican manufacturing subsidiary of the US-based drug delivery technology company DelSite, has received ISO re-certification for the next five years. Aenor International, an EU notified body, carried out the inspection, says the holding company. Sabila manufactures the Gelsite polymer, the raw material used to make the nasal powder used in the H5N1 antigen.
You may also be interested in...
In addition to agreeing to emergency use of the Oxford University/Astra Zeneca and Sinovac vaccines, Brazil's medicines regulator has also published good manufacturing practices certificates for Pfizer and Janssen vaccine. It has questions about the Sputnik V authorization request.
A Dutch parallel registration and reimbursement pilot has brought benefits including more participation from healthcare professionals, and also forces company divisions to be less streamlined.
The UK’s withdrawal from the EU could upset the Unitary Patent Court project.